These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3839875)

  • 1. [MOPP therapy of Hodgkin's disease previously treated with MOPP].
    Frau A; Montalar J
    Med Clin (Barc); 1985 May; 84(19):801. PubMed ID: 3839875
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hodgkin's lymphoma in children: results of treatment with the MOPP protocol and a combination of radiotherapy and chemotherapy].
    Vuković I; Janković MB; Janić D; Stojimirović E
    Srp Arh Celok Lek; 1985; 113(11-12):1013-21. PubMed ID: 3841764
    [No Abstract]   [Full Text] [Related]  

  • 3. Should MOPP-ABVD alone be standard for childhood Hodgkin's?
    Constine LS
    J Clin Oncol; 1998 Mar; 16(3):1235. PubMed ID: 9508214
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term results.
    Comella P; Abate G; Fiore M; Di Finizio G; Frezza P; Scoppa G; Anania C; Coucourde F; Zarrilli D
    J Chemother; 1989 Jul; 1(4 Suppl):1254-6. PubMed ID: 16312855
    [No Abstract]   [Full Text] [Related]  

  • 5. Mopp chemotherapy in the treatment of stage IV Hodgkin's disease.
    Fiacchini M; Lauria F; Mazza P; Cantore M; Gherlinzoni F; Tura S
    Haematologica; 1985; 70(2):148-54. PubMed ID: 3924778
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
    Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
    Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CVP or C-MOPP combination chemotherapy in the treatment of advanced Hodgkin's disease and non-Hodgkin's lymphoma (intermediate grade of working formulation)].
    Sampi K; Honda T; Hattori M
    Rinsho Ketsueki; 1984 Feb; 25(2):164-8. PubMed ID: 6547984
    [No Abstract]   [Full Text] [Related]  

  • 8. Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy.
    Diehl LF; Perry DJ; Terebelo H; Baldwin PE; Hurwitz M; Kimball DB; Dorn RV
    Cancer Treat Rep; 1983 Sep; 67(9):827-9. PubMed ID: 6883360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MOPP, ABVD, or both to treat Hodgkin's disease.
    Martino R; Nomdedeu J; Brunet S
    N Engl J Med; 1993 Apr; 328(14):1045; author reply 1045-6. PubMed ID: 7680766
    [No Abstract]   [Full Text] [Related]  

  • 10. A new combination chemotherapy for recurrent Hodgkin's lymphoma.
    Rahim MA; Sarma SK; Ahmed Q
    Bangladesh Med Res Counc Bull; 1982 Dec; 8(2):63-7. PubMed ID: 6897860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of dose and rate of administration of MOPP drugs in 97 retrospective Hodgkin's patients.
    Gobbi PG; Cavalli C; Rossi A; Bertoloni D; Galeone F; Pieresca C; Grignani E
    Haematologica; 1987; 72(6):523-8. PubMed ID: 3126109
    [No Abstract]   [Full Text] [Related]  

  • 12. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The management of Hodgkin's disease with chemotherapy or combined modality treatment].
    Tsushita K; Utsumi M; Shimoyama M
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2202-9. PubMed ID: 9881076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined-modality therapy for the treatment of Hodgkin's disease.
    Hoppe RT
    Front Radiat Ther Oncol; 1992; 26():172-80. PubMed ID: 1511919
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chemotherapy of patients with Hodgkin's disease].
    Onoshi T
    Nihon Naika Gakkai Zasshi; 1994 Jun; 83(6):912-6. PubMed ID: 7964042
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
    Olweny CL; Ziegler JL
    N Engl J Med; 2008 Feb; 358(7):742; author reply 743. PubMed ID: 18272899
    [No Abstract]   [Full Text] [Related]  

  • 17. Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation.
    Chow LM; Nathan PC; Hodgson DC; Jenkin D; Weitzman S; Grant RM; Manson D; Bross A; Doyle JJ; Danjoux C; Greenberg ML
    J Clin Oncol; 2006 Dec; 24(36):5735-41. PubMed ID: 17179107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of risk-adapted programs of treatment of Hodgkin's disease in children and adolescents].
    Kuleva SA
    Vopr Onkol; 2008; 54(6):768-70. PubMed ID: 19241857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
    Gobbi PG; Broglia C; Levis A; La Sala A; Valentino F; Chisesi T; Sacchi S; Corbella F; Cavanna L; Iannitto E; Pavone V; Molica S; Corazza GR; Federico M
    Clin Cancer Res; 2006 Jan; 12(2):529-35. PubMed ID: 16428496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hodgkin's disease in children; treatment results with or without radiotherapy].
    van Bunningen BN; Dewit L; Bartelink H
    Ned Tijdschr Geneeskd; 1986 May; 130(20):928-9. PubMed ID: 3755223
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.